Core Insights - The announcement of the completion of the ETHK building marks a significant milestone for the company as it transitions to a new strategic focus on blockchain technology and compliance in the financial ecosystem [4][5][8] - The new logo symbolizes the company's evolution into a builder of next-generation on-chain financial ecosystems, moving beyond its previous identity [4][8] Group 1: ETHK Building and Its Significance - The ETHK building is the world's first core base dedicated to the research and ecological empowerment of Real World Assets (RWA) digitalization technology, located in Nanjing with a total area of approximately 70,000 square meters [5][7] - The building serves a dual purpose: as a physical infrastructure for research and collaboration, and as a credible technology development and output center, expected to gather over 5,000 technical experts and engineers [7][8] - Nanjing was chosen for its strategic alignment with the company's focus on high-tech intellectual property asset digitalization and its proximity to top universities, providing talent support [7][8] Group 2: RWA Ecosystem and Strategic Transformation - The logo update and building completion represent the company's "second entrepreneurship," fully transitioning to the RWA sector, which involves the tokenization of real-world assets [8][9] - The RWA market is projected to grow significantly, with a total locked value expected to reach $12.5 billion by June 2025, a 124% increase from 2024 [8][9] - The company has established ETHK Inc. and ETHK HOLDINGS LIMITED to position itself as a technology driver and infrastructure provider in the RWA ecosystem [8][9] Group 3: Strategic Partnerships and Business Model Innovation - The company announced a strategic partnership with Renhe Pharmaceutical to establish the world's first OTC vertical RWA exchange in the U.S., marking a key case for its "exchange within an exchange" business model [9][10] - This innovative model aims to provide on-chain financial infrastructure for leading enterprises across various industries, facilitating the creation of vertical RWA exchanges [10] - The partnership is expected to enhance both parties' capabilities, enabling the internationalization of Chinese assets and the introduction of innovative OTC products from abroad [10][11] Group 4: Value Creation and Market Potential - The company's RWA strategy aims to create multidimensional value, emphasizing altruistic values and contributing to national strategies and public welfare [11][12] - The collaboration with Renhe Pharmaceutical is set to revolutionize the OTC industry by enhancing innovation efficiency across the entire value chain [11][12] - The RWA market is on the verge of significant growth, with major financial institutions entering the space, positioning the company to lead in this emerging sector [12][13]

Core Insights - The establishment of the ETHK Building in Nanjing marks the world's first core base focused on the research and development of Real World Assets (RWA) digitalization technology and ecosystem empowerment, symbolizing a new era for blockchain technology to integrate with the real economy [1][4][9] Group 1: Technological Foundation - The ETHK Building has a total construction area of approximately 70,000 square meters, designed as a "dual infrastructure" to serve as both a collaborative innovation base for over 5,000 technical experts and a technical hub for blockchain research and development [2][4] - It aims to provide comprehensive asset digitalization solutions across various vertical industries, addressing the complexity of RWA tokenization as a structural system engineering project [4][6] Group 2: Strategic Location in Nanjing - The choice of Nanjing for the RWA base is strategic, benefiting from a highly collaborative industrial ecosystem in the Yangtze River Delta, which is a core area for China's biopharmaceutical industry [5][6] - The location is also advantageous due to ongoing policy incentives, such as the approval of the Jiangsu Free Trade Zone's biopharmaceutical innovation development plan, which is expected to facilitate data cross-border flow and international rule alignment [5][6] - Nanjing's strong talent supply from institutions like China Pharmaceutical University and Nanjing University supports the ongoing research and development efforts at the ETHK Building [5][6] Group 3: Strategic Elevation - The company's rebranding to "ETHK Labs Inc." emphasizes its technology-driven positioning, with the new brand philosophy of "Technology for the Public, Chain to Carry the Way" being embodied in the ETHK Building [7][8] - The collaboration with Renhe Pharmaceutical to establish the first global OTC vertical RWA exchange in the U.S. exemplifies the company's commitment to empowering traditional industries through technology [8][9] Group 4: Market Potential and Vision - The completion of the ETHK Building signifies a shift in blockchain development from speculative activities to enhancing the value, efficiency, and liquidity of real assets [9] - According to Boston Consulting Group, the global RWA market is projected to reach $16.1 trillion by 2030, highlighting the significant market potential that the company aims to capture with its strategic initiatives [9]

Core Insights - The establishment of the ETHK building in Nanjing marks the launch of the world's first core base focused on the digitalization of Real World Assets (RWA) and signifies a strategic shift for the company towards becoming a global innovator in digital industries and on-chain financial infrastructure [1][6] Group 1: Technological Foundation - The ETHK building has a total construction area of approximately 70,000 square meters and is designed as a "dual infrastructure" to support over 5,000 technology experts and ecosystem collaborators [2] - It serves as a technical hub for blockchain research, cross-chain protocol integration, smart contract auditing, and regulatory technology (RegTech) development [2][4] Group 2: Strategic Location in Nanjing - The choice of Nanjing for the RWA base is strategic, aligning with the city's strong biopharmaceutical industry ecosystem, which is crucial for the company's focus on digitalizing biopharmaceutical intellectual property assets [5] - The building is situated within a policy innovation zone that supports the development of the biopharmaceutical industry, allowing the company to benefit from data cross-border flow and international regulatory alignment [5] - Nanjing's rich talent pool, supported by institutions like China Pharmaceutical University and Nanjing University, will provide ongoing research and development support for the ETHK building [5] Group 3: Strategic Elevation - The company's rebranding to "ETHK Labs Inc." emphasizes its technology-driven focus, with the new brand identity reflecting its commitment to technology and ecosystem empowerment [7] - The ETHK building embodies the vision of enabling blockchain technology to empower the real economy, as demonstrated by the company's collaboration with Renhe Pharmaceutical to establish the first OTC vertical RWA exchange in the U.S. [8] Group 4: Market Potential and Future Vision - The completion of the ETHK building signifies a new phase in blockchain development, transitioning from speculative activities to enhancing the value, efficiency, and liquidity of real assets [9] - According to Boston Consulting Group, the global RWA market is projected to reach $16.1 trillion by 2030, highlighting the transformative potential of the company's initiatives [9]

Group 1 - The core point of the article is that Huajian Medical (01931.HK) has officially completed the construction of the ETHK Building in Nanjing, China, which focuses on the research and development of digital technology for Real World Assets (RWA) [1] - This development marks a significant breakthrough in the company's "ETHK blockchain financial ecosystem strategy," emphasizing its commitment to foundational technology research and the construction of digital financial infrastructure [1] - The completion of the ETHK Building demonstrates the company's extraordinary determination and execution capability in transitioning from conceptual leadership to large-scale practical RWA technology development [1] Group 2 - As of September 19, 2025, Huajian Medical's stock closed at HKD 10.62, down 3.45%, with a trading volume of 533,000 shares and a turnover of HKD 5.7233 million [1] - The company has a market capitalization of HKD 17.804 billion, ranking second in the pharmaceutical commercial II industry [1] - Key financial metrics for Huajian Medical include a Return on Equity (ROE) of 4.69%, revenue of HKD 3.079 billion, and a net profit margin of 3.02%, with its debt ratio at 42.78% [1]

Core Viewpoint - The completion of the ETHK Building marks a significant milestone for the company, representing the first global hub dedicated to the research and development of Real World Asset (RWA) digitalization technology, and signifies the company's commitment to advancing its ETHK blockchain financial ecosystem strategy into a new era of physical and scalable technology implementation [1][5][7] Group 1: ETHK Building Overview - The ETHK Building, located in Nanjing, covers a total area of approximately 70,000 square meters, with the main building occupying about 35,000 square meters and additional facilities including a 20,000 square meter basement [1] - It is designed to serve as the headquarters for global RWA technology research and ecosystem empowerment, featuring state-of-the-art laboratories, data centers, and collaborative office spaces [2][3] Group 2: Strategic Importance - The choice of Nanjing as the location for the ETHK Building is strategic, leveraging the city's advantages in the biopharmaceutical industry and its mature innovation ecosystem [3][4] - The building aims to facilitate deep technological collaboration with potential partners, particularly in the innovative pharmaceutical sector, by providing comprehensive digital solutions for asset digitization and tokenization [3][4] Group 3: Technological Capabilities - The ETHK Building will integrate core technology research functions, including high-performance blockchain development, cross-chain interoperability, smart contract security, and regulatory technology [2][3] - It is expected to gather over 5,000 technical experts and partners, forming one of the largest and most capable RWA research teams globally [2] Group 4: Policy and Economic Context - The building is positioned within the core area of a supportive policy environment aimed at fostering innovation in the biopharmaceutical industry, as outlined in the recent government approval for the Jiangsu Free Trade Zone [4][5] - This policy framework is anticipated to provide significant benefits in areas such as data cross-border flow and international regulatory alignment, enhancing the company's global RWA business development [5] Group 5: Future Prospects - The establishment of the ETHK Building is seen as a testament to the company's technological ambitions and its commitment to delivering innovative solutions that empower the real economy [6][7] - The company plans to leverage this strategic asset to accelerate the implementation of innovative technologies and collaborate with global partners to create a promising future [7]

Core Viewpoint - The completion of the ETHK Building in Nanjing marks a significant milestone for the company in its strategy to develop a global digital financial ecosystem focused on Real World Assets (RWA) technology, transitioning from conceptualization to large-scale implementation [1][4]. Group 1: Infrastructure and Strategic Importance - The ETHK Building, with a total area of approximately 70,000 square meters, serves as the world's largest physical research and innovation base for RWA technology, featuring advanced facilities and a strategic location in the Yangtze River Delta economic zone [1][2]. - The building will act as the headquarters for RWA technology research and ecosystem empowerment, expected to gather over 5,000 technical experts and partners, facilitating a collaborative environment for innovation [1][2]. Group 2: Technological Development and Integration - The ETHK Building will integrate core technological research functions, including high-performance blockchain development, cross-chain interoperability, smart contract security, and RegTech solutions, providing comprehensive digital technology solutions for enterprises [2][4]. - The establishment of ETHK Inc and ETHK HOLDINGS LIMITED, with plans to rename as ETHK Labs Inc, emphasizes the company's role as a technology driver and infrastructure provider within the digital financial ecosystem [2][4]. Group 3: Talent and Collaboration - Nanjing's rich educational resources, including top universities and research institutions, will support the ETHK Building's technological research and foster collaboration opportunities, enhancing the company's competitive edge in technology innovation [3][4]. - The strategic location in Nanjing aligns with the company's focus on high-tech and high-potential intellectual property asset digitization, particularly in the biopharmaceutical sector [2][3]. Group 4: Policy and Market Positioning - The ETHK Building is positioned to benefit from favorable policies in the Jiangsu Free Trade Zone, which aims to create a world-class biopharmaceutical industry cluster, enhancing the company's global RWA business development [3][4]. - The building's inauguration is not just a physical milestone but a clear signal to the market and investors of the company's commitment to advancing its ETHK digital financial ecosystem strategy [4][5]. Group 5: Future Vision and Commitment - The ETHK Building symbolizes the company's long-term value and commitment to sustainable development, with future research outcomes expected to reinforce the global promotion of the ETHK digital financial technology ecosystem [5][6]. - The company aims to leverage this strategic asset to accelerate the implementation of innovative technologies, contributing to the efficient circulation and value discovery of quality global assets [6].

Core Insights - The establishment of the ETHK Building in Nanjing marks a significant milestone for the company in the development of digital technology focused on Real World Assets (RWA) [1] - This initiative represents a major breakthrough in the company's "ETHK Chain Financial Ecosystem Strategy," emphasizing its commitment to foundational technology research and the construction of digital financial infrastructure [1] Company Developments - The ETHK Building is located in a prime area of Nanjing, specifically at 190 Leshan Road, Jianye District, which is well-connected and serves the Yangtze River Delta economic zone [1] - The total construction area of the building is approximately 70,000 square meters, with the main building covering about 35,000 square meters, additional buildings around 15,000 square meters, and two underground levels totaling about 20,000 square meters [1] - This facility is touted as the largest and most comprehensive physical research and innovation base in the global RWA technology sector [1]

Group 1 - The core announcement from Huajian Medical includes the establishment of the ETHK building in Nanjing, which focuses on the research and development of Real World Asset (RWA) digitalization technology, marking a significant milestone in the company's transformation into a global innovator in digital industry and blockchain financial infrastructure [1][2] - The ETHK building spans approximately 70,000 square meters and aims to serve as a hub for over 5,000 technical experts and ecosystem partners, providing state-of-the-art laboratories, data centers, and testing environments [2][4] - The building will also function as a trusted technology research and output base, integrating capabilities in blockchain development, smart contract security auditing, cross-chain protocols, and regulatory technology [2][4] Group 2 - Huajian Medical's proactive approach to RWA infrastructure is driven by a deep understanding of technological trends, policy benefits, and market demands [4][5] - The global total locked value (TVL) of RWA is projected to reach $12.5 billion by June 2025, reflecting a 124% year-on-year growth, indicating a strong market potential for RWA tokenization [4][5] - The company has established a comprehensive capability chain through joint ventures, covering technology development, asset issuance, and compliance operations [4][5] Group 3 - Huajian Medical's RWA strategy is not merely a short-term capital initiative but a long-term strategic investment aimed at building a robust competitive moat [7][8] - The company has created a four-layer barrier consisting of technology, licenses, assets, and partnerships, which enhances its market position [7] - The vision includes enabling the globalization of Chinese assets through RWA technology, facilitating global pricing and financing opportunities [7][8] Group 4 - Huajian Medical's transformation represents a significant example of Chinese enterprises seizing opportunities in digital financial infrastructure [8] - The company aims to connect the real economy with the crypto world through RWA, positioning itself as a key player in the emerging digital finance landscape [8] - The strategic initiatives taken by Huajian Medical may play a crucial role in the narrative of Chinese asset globalization [8]

Core Viewpoint - Huajian Medical has announced the establishment of the ETHK Building in Nanjing, marking a significant milestone in its transformation into a global innovator in digital industry and blockchain financial infrastructure [1] Group 1: ETHK Building and Its Significance - The ETHK Building, with a total area of approximately 70,000 square meters, serves as the physical core of Huajian Medical's "ETHK Blockchain Financial Ecosystem Strategy" [2] - The building will host over 5,000 technical experts and partners, providing top-tier laboratories, data centers, and testing environments [2] - The completion of the ETHK Building signifies Huajian Medical's transition from conceptual leadership to large-scale physical implementation [2] Group 2: Strategic Advantages and Market Context - Huajian Medical's proactive approach to RWA infrastructure is supported by technological trends, policy benefits, and market demand [4] - The global total value locked (TVL) in RWA is projected to reach $12.5 billion by June 2025, reflecting a 124% year-on-year growth [4] - The company has established a comprehensive capability chain through joint ventures, covering technology, asset issuance, and compliance operations [4] Group 3: Long-term Strategy and Globalization - Huajian Medical's RWA strategy is a long-term investment aimed at building a robust competitive moat through technology, licensing, assets, and partnerships [6] - The company holds 5,190 ETH as treasury reserves and plans to increase its holdings, demonstrating confidence in the blockchain financial ecosystem [7] - The vision includes enabling Chinese quality assets to "go global" through RWA technology, facilitating global pricing and financing [7] Group 4: Broader Implications for the Industry - The establishment of the ETHK Building is a typical example of Chinese enterprises seizing opportunities in digital financial infrastructure [8] - As technology matures and regulations clarify, RWA is expected to become a crucial bridge connecting the real economy with the crypto world [8]

格隆汇9月19日丨华检医疗(01931.HK)宣布，为更准确反映集团全新战略定位及未来发展方向，公司决 定采用全新企业标志，自2025年9月19日起生效。公司的旧标志及新标志载列如下，以供识别： 公告显示，此次更新公司标志，并非止于视觉形象之更迭，而是集团战略愿景、生态格局与品牌哲学演 进的外在彰显，具有深远的战略意义与品牌价值。 新标志将印制于公司相关公司文件(包括但不限于中期及年度报告、公告、通函、通告、股票及新闻稿) 及将于公司官方网站展示。 ...